United States               Prevention, Pesticides         EPA-738-F-96-005
                  Environmental Protection       And Toxic Substances         December 1995
                  Agency	(7508W)	

                  R.E.D.   FACTS
                   Gibberellic   Acid	
      PGStJCJdG       All pesticides sold or distributed in the United States must be
R0TGClistration   registered by EPA, based on scientific studies showing that they can be used
                   without posing unreasonable risks to people or the environment.  Because of
                   advances in scientific knowledge, the law requires that pesticides which
                   were first registered before November 1, 1984, be reregistered to ensure
                   that they meet today's more stringent standards.
                       In evaluating pesticides for reregistration, EPA obtains and reviews a
                   complete set of studies from pesticide producers,  describing the human
                   health and environmental effects of each pesticide.  The Agency develops
                   mitigation measures or regulatory controls needed to effectively reduce each
                   pesticide's risks.  EPA then reregisters pesticides  that can be used without
                   posing unreasonable risks to human health or the  environment.
                       When a pesticide is eligible for reregistration, EPA explains the basis
                   for its decision in a Reregistration Eligibility Decision (RED) document.
                   This fact sheet summarizes the information in the RED document for
                   reregistration case number  4110, Gibberellic Acid.

    USG ProfilG       F°r the purpose of this RED,  the  following compounds will be
                   considered collectively under the term "Gibberellic Acids": Gibberellic Acid
                   (GA3); related isomers known as Gibberellins (GA4 + GA7); and the salt of
                   the acid, Potassium Gibberellate.
                            Gibberellic Acids are naturally occurring plant hormones.
                   Gibberellic Acids are used  in agriculture as plant  regulators to stimulate
                   both cell division and cell elongation that affect leaves as well as stems
                   (eventually affecting fruit development and fruit set). Applications of
                   Gibberellic Acids can also hasten plant maturation and seed germination.
                   Because they are naturally occurring compounds and have a nontoxic mode
                   of action in target plants, Gibberellic Acid and related isomers have been
                   classified as biochemical pesticides.
                       Gibberellic Acids are applied  to growing crops (field crops, small
                   fruits, vines and tree fruits), ornamental and shade tress, and ornamental
                   plants, shrubs and vines. The Agency has determined that the uses of
                   Gibberellic Acids,  as currently registered, will not cause unreasonable risk
                   to humans or the environment. These uses are eligible for reregistration.
                   However, six of the uses currently on the labels are not covered by either
                   the exemption from tolerance (40 CFR  180.1098), or a numeric tolerance

-------
                 (40 CFR 180.224). The Agency plans to propose to exempt from tolerance
                 many plant regulators, including Gibberellic Acids, when used in low doses.
                 This exemption will apply only when application rates do not exceed 250
                 grams of ai/acre/year. The Agency believes this action does not present
                 unreasonable risks because it is based on Gibberellic Acid's low acute
                 mammalian toxicity, low use rates, naturally occurring exposure in the diet
                 from numerous plant sources,  and minimal exposure in the diet derived
                 from consumption of treated commodities  under the proposed maximum
                 label use rate.

                 Formulation Types Registered:
                 Formulations include tablets, soluble granules, and liquid concentrate.

                 Method and Rates of Application:
                           Gibberellic Acid (GA3) and Gibberellin Mixture (GA4 + GA7):
                           Gibberellic Acid (GA3) and Gibberellin Mixtures (GA4 + GA7)
                           may be applied by aircraft,  irrigation systems, ground spray
                           equipment, seed treatment or soil incorporation.

                           Potassium Gibberellate:
                           Potassium Gibberellate may be applied by hand-held spray
                           equipment and as a seed treatment.
Regulatory
     History
Use Practice Limitations
           For terrestrial uses:
           "Do not apply directly to water or to areas where surface water
           is present or to intertidal areas below the mean high water
           mark."
           "Do not apply through any type of irrigation system."

           The plant regulator, Gibberellic Acid, was initially registered in
the United States in 1947 as PROVIDE GROWTH REGULATOR
SOLUTION (EPA Reg. No.  275-2)  for applications to apple trees as a
means of controlling fruit russet fungus. Gibberellic Acids are naturally
occurring plant hormones that act as plant regulators,  promoting cell
division and cell elongation leading to increased fruit set and crop yields.
      During Phase 4 of the accelerated pesticide reregistration process,  the
data base for Gibberellic Acids was evaluated and determined to be
inadequate in satisfying certain requirements for biochemical pesticides,
which include plant growth regulators. A  DCI was issued in September
1993 to fill the outstanding data gaps.

-------
                          The biochemical data requirements for the reregistration of Gibberellic
                     Acids have been satisfied through the submission of data in response to the
                     1993 DCI. These data are adequate to support the registration of Gibberellic
                     Acids on all RAC's, as well as all of the currently registered uses.

Human Health   Toxicity
  AsS6SSm6nt        In studies using laboratory animals, Gibberellic Acids generally have
                     been shown  to be of low acute toxicity.  The acute dermal toxicity
                     (LD50 > 2g/kg), acute inhalation (negative LC50 at 2.98mg/l and LC50
                     >5.9mg/l),  eye irritation  (all cleared in 7 days) place Gibberellic Acids in
                     Toxicity Category III  (the second lowest of four toxicity categories).
                     Gibberellic Acids acute toxicity (LD50 > 5g/kg), dermal irritation (mild to
                     slight), and dermal sensitization (mild sensitizer) place  it in Toxicity
                     Category IV (the  lowest of four toxicity categories).

                     [NOTE:  For acute oral, dietary, mammalian/avian/aquatic toxicity:
                                Category I = very highly or highly toxic
                                Category II = moderately toxic
                                Category III = slightly toxic
                                Category IV = practically non-toxic]

                     Subchronic Toxicity
                          Two subchronic oral toxicity studies for Gibberellic Acids were
                     reviewed in  connection with the RED process. In the first subchronic
                     dietary study there was a NOEL of 10,000 ppm and a LOEL of 50,000 ppm
                     based on the occurrence of soft stools in both sexes of rats and increased
                     BUN levels, liver and kidney weights in females. In the second study, there
                     was a NOEL of 10,000 ppm and a  LOEL of 25,000 ppm based  on
                     alterations in clinical chemistry, decreased food consumption, decreased
                     body weights,  increases in relative  organ weights (brain, kidney, testis) and
                     gross histopathological changes in the  kidney.

                     Developmental Toxicity
                          Two developmental toxicity studies for Gibberellic Acids were
                     reviewed for this RED. In the first study, rats were dosed at 0,  100, or
                     1,000 mg/kg/day  for 8 weeks without significant chemical, hematological or
                     pathologic evidence of toxicity.  The maternal toxicity NOEL was greater
                     than 1,000 mg/kg/day (HTD). In the second study, rabbits were dosed at 0,
                     300, or 1,000  mg/kg/day; the highest concentration caused increased
                     mortality,  abortion rates,  clinical signs of toxicity, and gross pathological
                     observations. The maternal and developmental NOELs were  established at
                     300 mg/kg/day.

-------
Mutagenicity
     Gibberellic Acid (GA3) Salmonella typhimurium test strains TA 98, TA
100, TA 1535, TA 1537, and TA 1538 at concentrations ranging from 0 to
10,000 ug/plate with negative test results up to limit dose of 5,000 and 10,000
ug/plate. The mutagenicity of Gibberellins  (GA4 + GA7) was tested in an Ames
assay with Salmonella typhimurium test strains TA 98, TA 100, TA 1535, TA
1537, and TA 1538 at concentrations ranging from 0 to 10,000 ug/plate.  Test
results were negative up to 10,000 ug/plate in the standard set of five histidine
negative strains of Salmonella typhimurium LT2.
     A mouse-micronucleus assay on Gibberellins (GA4 + GA7) indicated that no
increased incidence of micronucleated-polychromatic erythrocytes (m-PCE) were
found at levels up to 1200 mg/kg.
     An unscheduled  DNA synthesis in rat hepatocytes conducted with
Gibberellins technical  90% (GA4 + GA7) was negative for induction of UDS up to
1260 ug/ml, the limit of solubility (MRID  40261603). A second unscheduled
DNA synthesis in rat hepatocytes conducted with Gibberellins also was negative.

Dietary Exposure
     People may be exposed to residues of Gibberellic Acids through the diet.
Tolerances or maximum residue limits have been established for Gibberellic Acid
(GA3) and Gibberellins (GA4 + GA7)for the  following commodities (refer  to 40
CFR 180.224).

Gibberellic Acid (0.15 ppm)             Gibberellin Mixture (0.5  ppm)

Artichokes    Leafy vegetables         Apples
Blueberries   Stone fruits
Citrus  fruits  Sugarcane
Grapes      Sugarcane fodder
Hops        Sugarcane forage

-------
     An exemption from the requirement of a tolerance (40 CFR 180.1098) has
been established for Gibberellins (specifically GA3) when used as a plant regulator
at less than 20g ai/acre in or on the following RAC's:

Barley          Cucumbers            Oranges          Strawberries
Beans           Grapefruit             Peanuts          Squash
Beets (sugar)    Lemons                Peppers          Sugarcane
Broccoli        Lettuce                Potatoes          Tomatoes
Brussels sprouts  Melons                Rice            Turnips
Cabbage        Mints                  Rye             Watercress
Cauliflower     Mustard greens         Sorghum (milo)   Wheat
Corn (all)       Oats                   Soybean
Cotton          Onions                Spinach

     The Agency plans to propose an exemption from the requirements of a
tolerance for certain Gibberellic Acids (specifically Gibberellic Acid (GA3), a
mixture of Gibberellins  (GA4 + GA7), and Potassium Gibberellate) for all RAC's
when treated with application rates under 250 g ai/acre/year. The Agency believes
this action does not present unreasonable risks because it is based on Gibberellic
Acids' low mammalian toxicity, low use rates, natural background dietary
exposure and minimal exposure in the diet derived from consumption of treated
commodities under the proposed use rates.

Occupational  and Residential Exposure
     Based on the application methods listed on the product labels, the potential
for eye,  dermal,  and inhalation exposure to agricultural workers  does exist.
However,  the lack of acute toxicity (i.e., Gibberellic Acids are in Toxicity
Categories III  and IV) does not trigger additional requirements for evaluation of
worker exposure over the existing precautionary labeling currently required under
the provisions of the Worker Protection Standards.

Human Risk Assessment
     Since exposures and subsequent risks from Gibberellic Acids are not
expected,  any potential risks from exposures to treated plants will be mitigated by
use of baseline personal protective equipment required by the Worker Protection
Standards, supplemented by specific precautionary labeling required by this RED.
Post-application reentry workers are required to observe a 12 hour Restricted
Entry Interval. Because of Gibberellic Acid's low mammalian toxicity, however it
is a candidate for a reduced reentry interval from 12 hours to 4 hours.

-------
   Environmental
      Assessment
     Based on a review of all available ecological data, exposure
information, and Gibberellic Acids non-toxic mode of action, the Agency
expects that applications of Gibberellic Acids will pose minimal risk to
nontarget wildlife and fish.
     Environmental fate studies for biochemicals are not imposed unless
adverse effects are observed in ecological effects data. Since no adverse
effects are anticipated, the Agency will not, at this time, impose any
environmental fate data requirements for the currently registered uses  of
Gibberellic Acids.
  Additional Data
          Required
Product Labeling
          Changes
          Required
        Regulatory
       Conclusion
          For More
       Information
     EPA is requiring the a revised Confidential Statement of Formula
(CSF) and revised product labeling for reregistration.

     The Agency has  reexamined the toxicological data base for
Gibberellic Acid s and concluded that the current precautionary labeling
(i.e., Signal Word , Statement of Practical Treatment,  and other label
statements associated with mitigating risks) adequately mitigate any risks
associated with the use of this plant regulator.

     Based on the reviews of the generic data for Gibberellic Acid, the
Agency has sufficient information on health effect and potential for causing
adverse effects to human s or the environment. Therefore, the Agency
concludes that the use of currently registered products containing
Gibberellic Acids in accordance with approved labeling will not pose
unreasonable risks or adverse effects to humans or the environment. Certain
uses of Gibberellic Acids that have neither a tolerance  or an exemption from
tolerance requirements (i.e., food use/commodities not listed in 40 CFR
180.224 or 40 CFR 180.1098) will become eligible for reregistration when
the proposed tolerance exemption is issued as a final rule in 1996.

     EPA is requesting public comments on the Reregistration Eligibility
Decision (RED) document for [name] during a 60-day time period, as
announced in a Notice of Availability published in the  Federal Register.  To
obtain a copy of the RED document or to submit written comments, please
contact the Pesticide Docket, Public Response and Program Resources
Branch, Field Operations Division (7506C), Office of Pesticide Programs
(OPP), US  EPA, Washington, DC 20460, telephone 703-305-5805.
     Electronic copies of the RED and this fact sheet can be downloaded
from the Pesticide Special Review and Reregistration Information System at
703-308-7224. They also are available on the  Internet on EPA's gopher
server,  GOPHER.EPA. GOV, or using ftp on FTP.EPA.GOV, or using
WWW (World Wide Web) on WWW.EPA.GOV.
     Printed copies of the RED and fact sheet can be  obtained from EPA's
National Center for Environmental Publications and Information

-------
(EPA/NCEPI), PO Box 42419, Cincinnati, OH 45242-0419, telephone
513-489-8190, fax 513-489-8695.
     Following the comment period, the Gibberellic Acid RED document
also will be available  from the National Technical Information Service
(NTIS), 5285 Port Royal Road, Springfield, VA 22161, telephone 703-487-
4650.
     For more information about EPA's pesticide reregistration program,
the Gibberellic Acid RED, or reregistration of individual products
containing Gibberellic Acid, please contact the Biopesticides and Pollution
Prevention Division (7501W), OPP, US EPA, Washington, DC 20460,
telephone 703-308-8712.
     For information about the health effects of pesticides,  or for assistance
in recognizing and managing pesticide poisoning symptoms, please contact
the National Pesticides Telecommunications Network (NPTN).  Call toll-
free 1-800-858-7378, between 9:30 am and 7:30 pm Eastern Standard
Time, Monday through Friday.

-------